4//SEC Filing
Smith Jason Drew 4
Accession 0001437749-25-002685
CIK 0001668243other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 11:51 AM ET
Size
20.3 KB
Accession
0001437749-25-002685
Insider Transaction Report
Form 4
Smith Jason Drew
General Counsel
Transactions
- Sale
Ordinary Shares
2025-01-31$11.14/sh−3,354$37,364→ 29,781 total - Sale
Ordinary Shares
2025-01-31$11.14/sh−2,767$30,824→ 32,514 total - Exercise/Conversion
Restricted Stock Units
2025-01-31−2,500→ 0 total→ Ordinary Shares (2,500 underlying) - Exercise/Conversion
Restricted Stock Units
2025-01-31−5,500→ 11,000 total→ Ordinary Shares (5,500 underlying) - Exercise/Conversion
Ordinary Shares
2025-01-31+6,667→ 33,135 total - Exercise/Conversion
Restricted Stock Units
2025-01-31−6,667→ 6,667 total→ Ordinary Shares (6,667 underlying) - Sale
Ordinary Shares
2025-01-31$11.14/sh−1,258$14,014→ 26,468 total - Exercise/Conversion
Ordinary Shares
2025-01-31+5,500→ 35,281 total - Award
Restricted Stock Units
2025-01-31+10,000→ 10,000 total→ Ordinary Shares (10,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-01-31+2,500→ 27,726 total
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted RSUs on January 31, 2022 representing 7,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
- [F4]The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
- [F5]The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
- [F6]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2026, January 31, 2027 and January 31, 2028.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001821479
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 11:51 AM ET
- Size
- 20.3 KB